Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is a publicly traded Healthcare sector company. As of July 13, 2026, MDGL trades at $532.91 with a market cap of $12.37B and a P/E ratio of -49.72. MDGL moved -0.76% today. Year to date, MDGL is -8.06%; over the trailing twelve months it is +70.58%. Its 52-week range spans $265.00 to $615.00. Analyst consensus is strong buy with an average price target of $669.06. Rallies surfaces MDGL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for MDGL, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $532.91 |
| Market Cap | $12.37B |
| P/E Ratio | -49.72 |
| EPS | $-10.79 |
| Dividend Yield | 0.00% |
| 52-Week High | $615.00 |
| 52-Week Low | $265.00 |
| Volume | 82.93K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.13B |
| Net Income | $-309.44M |
| Gross Margin | 0.00% |
10 analysts cover MDGL: 0 strong buy, 9 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $669.06.